Lv33
390 积分 2026-01-24 加入
868P Phase II trial of ozuriftamab vedotin (BA3021), a conditionally active biologic (CAB)-ROR2-ADC, in patients with recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN)
9天前
已关闭
Machine Learning–Driven Risk Stratification and Adjuvant Treatment Guidance in Oral Cavity Cancer
21天前
已关闭
Met-Targeted Dual-Modal MRI/NIR II Imaging for Specific Recognition of Head and Neck Squamous Cell Carcinoma
22天前
已完结
Imaging of Colorectal Cancers Using Activatable Nanoprobes with Second Near‐Infrared Window Emission
26天前
已完结
A bright NIR-II fluorescent probe for breast carcinoma imaging and image-guided surgery
27天前
已完结
NIR‐II Fluorescence Endoscopy for Targeted Imaging of Colorectal Cancer
27天前
已完结
First-in-human liver-tumour surgery guided by multispectral fluorescence imaging in the visible and near-infrared-I/II windows
27天前
已完结
Engineering Oxaliplatin Prodrug Nanoparticles for Second Near‐Infrared Fluorescence Imaging‐Guided Immunotherapy of Colorectal Cancer
27天前
已完结
Visualizing Tumors in Real Time: A Highly Sensitive PSMA Probe for NIR-II Imaging and Intraoperative Tumor Resection
28天前
已完结
Responsive optical probes for deep-tissue imaging: Photoacoustics and second near-infrared fluorescence
28天前
已完结
皖公网安备34019202002308
